National pharmacy organizations voiced strong support for new pharmacy benefit manager oversight measures included in funding legislation Congress passed Feb. 3, calling the changes a major step toward curbing practices they say have harmed pharmacies and patients.
The legislation directs CMS to strengthen Medicare Part D oversight by defining and enforcing pharmacy contract terms, tracking payment and network trends beginning in 2028 and authorizing audits and enforcement actions requiring PBMs to repay money they were not allowed to keep. It also prohibits PBM compensation from being tied to drug list prices and establishes timelines for additional standards in 2028, with full implementation slated for Jan. 1, 2029. Those changes include protections allowing any willing pharmacy that meets requirements to join a network.
The National Association of Chain Drug Stores called the vote a “historic win” for pharmacies and patients, adding that the reforms must be implemented swiftly and as intended to address abuses by PBM middlemen.
The American Society of Health-System Pharmacists echoed that sentiment, calling the legislation an important step toward curbing PBM practices that, it contends, have undermined pharmacists’ ability to deliver safe, effective care. The group urged Congress to continue pursuing reforms that increase transparency and preserve patient access.
The Community Oncology Alliance described the bill as a lifesaving measure for cancer patients, alleging that PBM practices have contributed to pharmacy and medical deserts. The group said Congress must take additional steps because PBMs continue to find ways to profit at patients’ expense.
The National Community Pharmacists Association applauded President Donald Trump’s signing of the bill and highlighted provisions requiring CMS to define and enforce Medicare Part D contract terms, track payment trends and designate essential retail pharmacies. The group said its advocacy efforts generated nearly 100,000 letters to Congress in support of reform.
The American Pharmacists Association said the reforms mark meaningful progress toward strengthening pharmacy reimbursement in Medicare, but criticized Congress for excluding legislation to cover pharmacists’ care services. The group said lasting improvements require recognizing and paying for the clinical services pharmacists provide.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
